34 Per Cent Returns From 52-Week Low: Penny Stock Under Rs 5 Jumps Over 9 Per Cent Today
The stock is up by 34 per cent from its 52-week low of Rs 1.94 per share.
On Thursday, one of the Top Gainers on BSE, shares of Evexia Lifecare jumped 9.70 per cent to Rs 2.60 per share from its previous closing of Rs 2.37 per share. The stock is up by 34 per cent from its 52-week low of Rs 1.94 per share.
Evexia Lifecare Limited, formerly known as Kavit Industries Limited, is engaged in the trading of chemicals, agricultural produce and various other products of consumer goods. The company has also formed a new subsidiary firm to set up pathology labs in Africa.
According to the financials, this FMCG company has a market cap of Rs 488 crore and reported positive numbers in its Quarterly Results (Q3FY25) and nine-month results (9MFY25). In its quarterly results, the net sales increased by 221 per cent to Rs 21.70 crore and net profit increased by 340 per cent to Rs 0.12 crore in Q3FY25 compared to Q3FY24 while in its nine-month results, the net sales increased by 122 per cent to Rs 69.64 crore and net profit increased by 170 per cent to Rs 1.05 crore in 9MFY25 compared to 9MFY24.
DSIJ's ‘Penny Pick’ service provides research-backed penny stock recommendations below Rs. 100. If this interests you, do download the service details here.
Earlier, Evexia Lifecare Limited undertook significant strategic moves to bolster its pharmaceutical business. The company has allotted 24 crore convertible warrants to Raghuvir International Pvt Ltd and Shree Saibaba Exim Pvt Ltd, raising capital to fuel future growth. Additionally, Evexia has entered into a Term Sheet with DIPOned Research International Private Limited to acquire a 65 per cent stake, aiming to expand its operations into drug discovery, development, and contract research services, thereby diversifying its portfolio and tapping into a new market
Investors should keep an eye on this micro-cap stock under the radar.
Disclaimer: The article is for informational purposes only and not investment advice.